COM:FATETHERAPEUTICS
Fate Therapeutics
- Stock
Last Close
2.22
21/11 21:00
Market Cap
355.16M
Beta: -
Volume Today
1.93M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | |||||||||||
average payables | 1.60M - | 663.50K 58.54% | 820.50K 23.66% | 965K 17.61% | 1.31M 35.34% | 2.94M 125.23% | 5.01M 70.44% | 6.05M 20.72% | 7.45M 23.05% | 8.44M 13.31% | 6.49M 23.07% | |
average receivables | 250K - | 919K 267.60% | 3.43M 272.85% | 7.10M 107.08% | 23.58M 232.30% | 20.15M 14.53% | ||||||
book value per share | 8.62 - | 1.39 83.93% | 1.49 7.72% | 2.30 54.34% | 1.84 20.19% | 2.86 55.31% | 3.59 25.70% | 4.67 30.01% | 7.16 53.54% | 5.00 30.24% | 0.00 99.93% | |
capex per share | -0.04 - | -0.04 4.21% | -0.06 36.30% | -0.01 75.52% | -0.04 185.50% | -0.04 0.26% | -0.11 164.62% | -0.06 44.80% | -0.54 793.93% | -0.37 31.36% | -0.00 99.98% | |
capex to depreciation | -0.43 - | -1.78 316.13% | -2.18 22.62% | -0.52 76.21% | -1.78 242.48% | -1.91 7.67% | -3.37 76.29% | -1.60 52.62% | -8.67 442.50% | -2.59 70.17% | -0.89 65.42% | |
capex to operating cash flow | 0.02 - | 0.04 147.87% | 0.08 106.97% | 0.02 81.18% | 0.05 205.03% | 0.06 27.48% | 0.09 49.21% | 0.13 41.41% | 0.31 147.62% | 0.14 53.97% | 0.05 67.53% | |
capex to revenue | -0.25 - | -0.62 - | -0.10 83.15% | -0.42 304.67% | -0.49 15.65% | -0.69 42.51% | -0.16 77.34% | -0.91 478.66% | -0.37 59.32% | -0.10 73.78% | ||
cash per share | 9.16 - | 2.40 73.80% | 2.54 5.93% | 2.90 14.07% | 2.40 17.11% | 3.58 48.75% | 3.25 9.22% | 5.86 80.52% | 6.50 10.90% | 4.51 30.69% | 0.00 99.93% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 38.50 - | 45.73 18.77% | 64.04 40.04% | 56.70 11.45% | 145.85 157.21% | 10.49 92.81% | ||||||
debt to assets | 0.03 - | 0.38 1,130.24% | 0.27 29.99% | 0.11 58.10% | 0.21 86.34% | 0.07 66.66% | 0.09 27.50% | 0.16 75.47% | 0.12 20.28% | 0.15 24.37% | 0.20 31.98% | |
debt to equity | 0.03 - | 0.69 1,933.41% | 0.48 30.78% | 0.15 69.53% | 0.29 95.63% | 0.09 67.55% | 0.11 18.61% | 0.25 130.05% | 0.17 33.17% | 0.23 33.58% | 0.28 24.39% | |
dividend yield | 0.00 - | 0.00 52.28% | 0.06 2,440.05% | 0.00 - | ||||||||
earnings yield | -0.56 - | -0.25 55.41% | -0.35 38.80% | -0.42 20.22% | -0.17 60.12% | -0.09 44.84% | -0.07 20.73% | -0.02 68.95% | -0.04 63.70% | -0.26 601.53% | -0.00 99.83% | |
enterprise value | -15.28M - | 73.40M 580.50% | 39.31M 46.44% | 1.78M 95.47% | 182.37M 10,134.46% | 545.36M 199.05% | 1.26B 131.33% | 7.42B 488.24% | 5.52B 25.55% | 1.02B 81.45% | 368.12B 35,814.79% | |
enterprise value over ebitda | 0.89 - | -2.95 429.91% | -1.42 51.98% | -0.06 96.04% | -4.39 7,736.02% | -8.40 91.52% | -13.09 55.75% | -59.05 351.16% | -25.62 56.62% | -3.32 87.02% | -1.93K 58,036.38% | |
ev to operating cash flow | 0.99 - | -3.27 429.48% | -2.14 34.73% | -0.06 97.20% | -4.94 8,170.49% | -14.11 185.54% | -15.17 7.50% | -189.18 1,147.21% | -33.92 82.07% | -4.13 87.83% | -2.78K 67,298.58% | |
ev to sales | -15.73 - | 16.17 - | 0.40 97.50% | 44.41 10,872.26% | 115.05 159.05% | 118.13 2.67% | 236.09 99.86% | 98.93 58.10% | 10.64 89.24% | 5.79K 54,337.76% | ||
free cash flow per share | -2.65 - | -1.14 56.99% | -0.78 31.48% | -0.95 22.15% | -0.92 3.51% | -0.73 20.80% | -1.33 82.25% | -0.54 59.64% | -2.25 320.53% | -2.93 30.02% | -0.00 99.95% | |
free cash flow yield | -0.42 - | -0.23 46.30% | -0.23 2.27% | -0.38 64.00% | -0.15 60.36% | -0.06 62.28% | -0.07 19.48% | -0.01 91.31% | -0.04 553.54% | -0.29 653.94% | -0.00 99.87% | |
graham net net | 8.36 - | 1.28 84.66% | 1.37 6.72% | 2.21 61.52% | 1.74 21.53% | 2.65 52.62% | 2.42 8.68% | 3.02 24.99% | 4.01 32.61% | 2.51 37.27% | 0.00 99.93% | |
graham number | 26.22 - | 6.28 76.04% | 6.29 0.08% | 7.39 17.56% | 6.51 11.97% | 8.73 34.13% | 10.76 23.28% | 14.73 36.95% | 18.74 27.17% | 17.21 8.13% | 0.01 99.93% | |
income quality | 0.74 - | 0.87 17.72% | 0.61 29.18% | 0.89 45.30% | 0.86 3.59% | 0.58 32.46% | 0.85 46.02% | 0.23 73.30% | 0.77 239.32% | 0.88 14.76% | 0.82 6.72% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -22.20 - | -45.36 104.29% | -12.51 72.41% | -19.53 56.02% | -33.22 70.15% | -39.56 19.08% | -57.49 45.33% | -52.79 - | ||||
interest debt per share | 0.43 - | 0.99 130.11% | 0.80 18.63% | 0.39 51.65% | 0.56 43.17% | 0.30 46.91% | 0.42 42.55% | 1.18 180.81% | 1.21 2.61% | 1.19 1.84% | 0.00 99.91% | |
inventory turnover | ||||||||||||
invested capital | 0.03 - | 0.69 1,933.41% | 0.48 30.78% | 0.15 69.53% | 0.29 95.63% | 0.09 67.55% | 0.11 18.61% | 0.25 130.05% | 0.17 33.17% | 0.23 33.58% | 0.28 24.39% | |
market cap | 37.03M - | 102.87M 177.82% | 85.88M 16.52% | 79.70M 7.19% | 256.51M 221.83% | 720.99M 181.08% | 1.33B 85.09% | 7.49B 461.36% | 5.54B 26.00% | 976.97M 82.38% | 368.06B 37,573.20% | |
net current asset value | 49.92M - | 27.01M 45.89% | 35.73M 32.30% | 71.43M 99.90% | 74.49M 4.29% | 152.63M 104.90% | 169.57M 11.10% | 256.31M 51.15% | 390.80M 52.47% | 280.45M 28.24% | 193.74M 30.92% | |
net debt to ebitda | 3.06 - | 1.18 61.31% | 1.68 41.69% | 2.45 46.01% | 1.78 27.15% | 2.71 51.71% | 0.76 72.06% | 0.56 26.29% | 0.09 84.39% | -0.16 278.92% | -0.32 107.94% | |
net income per share | -3.54 - | -1.27 64.29% | -1.18 7.01% | -1.05 10.46% | -1.02 2.91% | -1.19 15.84% | -1.43 20.91% | -2.07 44.26% | -2.18 5.33% | -2.63 20.98% | -0.00 99.94% | |
operating cash flow per share | -2.61 - | -1.10 57.96% | -0.72 34.14% | -0.94 30.10% | -0.88 6.40% | -0.69 21.76% | -1.22 77.35% | -0.48 60.96% | -1.72 261.01% | -2.56 49.12% | -0.00 99.95% | |
payables turnover | ||||||||||||
receivables turnover | 9.48 - | 7.98 15.80% | 5.70 28.59% | 6.44 12.93% | 2.50 61.12% | 34.79 1,290.30% | ||||||
research and ddevelopement to revenue | 12.37 - | 8.17 - | 6.01 26.45% | 8.37 39.25% | 11.82 41.25% | 8.22 30.47% | 4.00 51.37% | 3.86 3.43% | 3.33 13.77% | 2.72 18.36% | ||
return on tangible assets | -0.38 - | -0.51 34.47% | -0.44 12.69% | -0.35 20.23% | -0.41 15.87% | -0.31 23.36% | -0.32 3.40% | -0.27 15.36% | -0.22 18.17% | -0.36 61.46% | -0.32 12.06% | |
revenue per share | 0.16 - | 0.10 - | 0.14 45.32% | 0.10 29.45% | 0.08 13.76% | 0.16 85.68% | 0.38 143.61% | 0.59 54.48% | 0.99 68.74% | 0.00 99.94% | ||
roe | -0.41 - | -0.91 122.26% | -0.79 13.67% | -0.46 41.99% | -0.56 21.65% | -0.42 25.42% | -0.40 3.81% | -0.44 10.96% | -0.30 31.40% | -0.53 73.42% | -0.44 17.12% | |
roic | -0.35 - | -0.52 49.08% | -0.48 7.25% | -0.37 22.75% | -0.43 14.65% | -0.40 7.53% | -0.34 15.03% | -0.22 35.30% | -0.23 6.91% | -0.40 71.08% | -0.33 16.69% | |
sales general and administrative to revenue | 6.84 - | 4.26 - | 2.25 47.12% | 2.89 28.41% | 3.34 15.33% | 2.21 33.64% | 1.08 51.28% | 1.03 4.81% | 0.87 14.78% | 1.28 46.56% | ||
shareholders equity per share | 8.62 - | 1.39 83.93% | 1.49 7.72% | 2.30 54.34% | 1.84 20.19% | 2.86 55.31% | 3.59 25.70% | 4.67 30.01% | 7.16 53.54% | 5.00 30.24% | 0.00 99.93% | |
stock based compensation to revenue | 1.60 - | 0.99 - | 0.72 26.73% | 0.88 21.42% | 1.33 51.17% | 1.63 22.79% | 0.98 39.98% | 0.97 0.50% | 0.82 16.01% | 0.68 16.33% | ||
tangible asset value | 50.85M - | 28.34M 44.27% | 38.04M 34.22% | 73.15M 92.32% | 77.19M 5.52% | 160.47M 107.89% | 244.76M 52.53% | 384.44M 57.07% | 678.84M 76.58% | 483.94M 28.71% | 368.42M 23.87% | |
tangible book value per share | 8.62 - | 1.39 83.93% | 1.49 7.72% | 2.30 54.34% | 1.84 20.19% | 2.86 55.31% | 3.59 25.70% | 4.67 30.01% | 7.16 53.54% | 5.00 30.24% | 0.00 99.93% | |
working capital | 50.05M - | 45.29M 9.51% | 52.21M 15.28% | 78.14M 49.65% | 91.55M 17.16% | 177.93M 94.36% | 199.28M 12.00% | 408.76M 105.11% | 552.13M 35.07% | 388.02M 29.72% | 292.45M 24.63% |
All numbers in (except ratios and percentages)